Phototherapy for Sclerosing Skin Conditions CME
Rebecca Vasquez, MD; Heidi Jacobe, MD, MSCS
Phototherapy is efficacious for a variety of sclerosing skin conditions. It is particularly attractive because many of these disorders are considered unresponsive to other therapies. Furthermore, phototherapy offers an alternative to systemic immunosuppressives for patients who cannot tolerate these medications. There are a number of phototherapeutic modalities used for the treatment of sclerosing skin conditions; here, we review the current evidence for the use of UVA1, broadband UVA1, psoralen plus UVA and narrowband UVB phototherapy.
Among the most therapeutically challenging entities in dermatology, sclerosing skin disorders are a cause of significant morbidity and can impact quality of life. Immunosuppressives have recently shown promise in morphea, but remain controversial for other sclerotic skin disorders with no clear evidence for their efficacy. Additionally, some patients are unable to tolerate or have contraindications to immunosuppressive therapy. Phototherapy offers an efficacious and safe alternative and is quickly becoming an attractive therapeutic option.